2024-01-012024-12-312024-12-31false03097916Collinson Grant Limited2025-09-26falseiso4217:GBPxbrli:pure030979162023-12-31030979162024-12-31030979162024-01-012024-12-31030979162022-12-31030979162023-12-31030979162023-01-012023-12-3103097916bus:SmallEntities2024-01-012024-12-3103097916bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3103097916bus:FullAccounts2024-01-012024-12-3103097916bus:PrivateLimitedCompanyLtd2024-01-012024-12-3103097916core:WithinOneYear2024-12-3103097916core:AfterOneYear2024-12-3103097916core:WithinOneYear2023-12-3103097916core:AfterOneYear2023-12-3103097916core:ShareCapital2024-12-3103097916core:SharePremium2024-12-3103097916core:RevaluationReserve2024-12-3103097916core:OtherReservesSubtotal2024-12-3103097916core:RetainedEarningsAccumulatedLosses2024-12-3103097916core:ShareCapital2023-12-3103097916core:SharePremium2023-12-3103097916core:RevaluationReserve2023-12-3103097916core:OtherReservesSubtotal2023-12-3103097916core:RetainedEarningsAccumulatedLosses2023-12-3103097916core:LandBuildings2024-12-3103097916core:PlantMachinery2024-12-3103097916core:Vehicles2024-12-3103097916core:FurnitureFittings2024-12-3103097916core:OfficeEquipment2024-12-3103097916core:NetGoodwill2024-12-3103097916core:IntangibleAssetsOtherThanGoodwill2024-12-3103097916core:ListedExchangeTraded2024-12-3103097916core:UnlistedNon-exchangeTraded2024-12-3103097916core:LandBuildings2023-12-3103097916core:PlantMachinery2023-12-3103097916core:Vehicles2023-12-3103097916core:FurnitureFittings2023-12-3103097916core:OfficeEquipment2023-12-3103097916core:NetGoodwill2023-12-3103097916core:IntangibleAssetsOtherThanGoodwill2023-12-3103097916core:ListedExchangeTraded2023-12-3103097916core:UnlistedNon-exchangeTraded2023-12-3103097916core:LandBuildings2024-01-012024-12-3103097916core:PlantMachinery2024-01-012024-12-3103097916core:Vehicles2024-01-012024-12-3103097916core:FurnitureFittings2024-01-012024-12-3103097916core:OfficeEquipment2024-01-012024-12-3103097916core:NetGoodwill2024-01-012024-12-3103097916core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3103097916core:ListedExchangeTraded2024-01-012024-12-3103097916core:UnlistedNon-exchangeTraded2024-01-012024-12-3103097916core:MoreThanFiveYears2024-01-012024-12-3103097916core:Non-currentFinancialInstruments2024-12-3103097916core:Non-currentFinancialInstruments2023-12-3103097916dpl:CostSales2024-01-012024-12-3103097916dpl:DistributionCosts2024-01-012024-12-3103097916core:LandBuildings2024-01-012024-12-3103097916core:PlantMachinery2024-01-012024-12-3103097916core:Vehicles2024-01-012024-12-3103097916core:FurnitureFittings2024-01-012024-12-3103097916core:OfficeEquipment2024-01-012024-12-3103097916dpl:AdministrativeExpenses2024-01-012024-12-3103097916core:NetGoodwill2024-01-012024-12-3103097916core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3103097916dpl:GroupUndertakings2024-01-012024-12-3103097916dpl:ParticipatingInterests2024-01-012024-12-3103097916dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3103097916core:ListedExchangeTraded2024-01-012024-12-3103097916dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3103097916core:UnlistedNon-exchangeTraded2024-01-012024-12-3103097916dpl:CostSales2023-01-012023-12-3103097916dpl:DistributionCosts2023-01-012023-12-3103097916core:LandBuildings2023-01-012023-12-3103097916core:PlantMachinery2023-01-012023-12-3103097916core:Vehicles2023-01-012023-12-3103097916core:FurnitureFittings2023-01-012023-12-3103097916core:OfficeEquipment2023-01-012023-12-3103097916dpl:AdministrativeExpenses2023-01-012023-12-3103097916core:NetGoodwill2023-01-012023-12-3103097916core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3103097916dpl:GroupUndertakings2023-01-012023-12-3103097916dpl:ParticipatingInterests2023-01-012023-12-3103097916dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3103097916core:ListedExchangeTraded2023-01-012023-12-3103097916dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3103097916core:UnlistedNon-exchangeTraded2023-01-012023-12-3103097916core:NetGoodwill2024-12-3103097916core:IntangibleAssetsOtherThanGoodwill2024-12-3103097916core:LandBuildings2024-12-3103097916core:PlantMachinery2024-12-3103097916core:Vehicles2024-12-3103097916core:FurnitureFittings2024-12-3103097916core:OfficeEquipment2024-12-3103097916core:AfterOneYear2024-12-3103097916core:WithinOneYear2024-12-3103097916core:ListedExchangeTraded2024-12-3103097916core:UnlistedNon-exchangeTraded2024-12-3103097916core:ShareCapital2024-12-3103097916core:SharePremium2024-12-3103097916core:RevaluationReserve2024-12-3103097916core:OtherReservesSubtotal2024-12-3103097916core:RetainedEarningsAccumulatedLosses2024-12-3103097916core:NetGoodwill2023-12-3103097916core:IntangibleAssetsOtherThanGoodwill2023-12-3103097916core:LandBuildings2023-12-3103097916core:PlantMachinery2023-12-3103097916core:Vehicles2023-12-3103097916core:FurnitureFittings2023-12-3103097916core:OfficeEquipment2023-12-3103097916core:AfterOneYear2023-12-3103097916core:WithinOneYear2023-12-3103097916core:ListedExchangeTraded2023-12-3103097916core:UnlistedNon-exchangeTraded2023-12-3103097916core:ShareCapital2023-12-3103097916core:SharePremium2023-12-3103097916core:RevaluationReserve2023-12-3103097916core:OtherReservesSubtotal2023-12-3103097916core:RetainedEarningsAccumulatedLosses2023-12-3103097916core:NetGoodwill2022-12-3103097916core:IntangibleAssetsOtherThanGoodwill2022-12-3103097916core:LandBuildings2022-12-3103097916core:PlantMachinery2022-12-3103097916core:Vehicles2022-12-3103097916core:FurnitureFittings2022-12-3103097916core:OfficeEquipment2022-12-3103097916core:AfterOneYear2022-12-3103097916core:WithinOneYear2022-12-3103097916core:ListedExchangeTraded2022-12-3103097916core:UnlistedNon-exchangeTraded2022-12-3103097916core:ShareCapital2022-12-3103097916core:SharePremium2022-12-3103097916core:RevaluationReserve2022-12-3103097916core:OtherReservesSubtotal2022-12-3103097916core:RetainedEarningsAccumulatedLosses2022-12-3103097916core:AfterOneYear2024-01-012024-12-3103097916core:WithinOneYear2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3103097916core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3103097916core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3103097916core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3103097916core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3103097916core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3103097916bus:Director12024-01-012024-12-3103097916bus:Director22024-01-012024-12-3103097916bus:Director32024-01-012024-12-3103097916bus:Director42024-01-012024-12-3103097916bus:Director52024-01-012024-12-3103097916bus:Director62024-01-012024-12-3103097916core:FurnitureFittingsToolsEquipment2023-12-3103097916core:FurnitureFittingsToolsEquipment2024-01-012024-12-3103097916core:FurnitureFittingsToolsEquipment2024-12-31

Collinson Grant Limited

Registered Number
03097916
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

Collinson Grant Limited
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

A Collinson
B Collinson
S Millman
K Morgan
P Ross
P Weekes

Company Secretary

P Leary

Registered Address

Ryecroft
Aviary Road
Worsley
M28 2WF

Registered Number

03097916 (England and Wales)
Collinson Grant Limited
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets44666,792
4666,792
Current assets
Debtors52,283,8861,554,361
Cash at bank and on hand310,342389,305
2,594,2281,943,666
Creditors amounts falling due within one year6(1,959,633)(1,287,139)
Net current assets (liabilities)634,595656,527
Total assets less current liabilities635,061663,319
Net assets635,061663,319
Capital and reserves
Called up share capital700700
Profit and loss account634,361662,619
Shareholders' funds635,061663,319
The financial statements were approved and authorised for issue by the Board of Directors on 26 September 2025, and are signed on its behalf by:
A Collinson
Director
Registered Company No. 03097916
Collinson Grant Limited
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities, except that the deficit arising from the most recent actuarial valuation of the company's defined benefit pension scheme at 30th September 2021 has not been recognised in the statement of financial position.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover consists of revenue earned from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company participates in a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Any contributions unpaid at the balance sheet date are recognised within other creditors in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Defined benefit pension plan
The company operates a defined benefit scheme for directors and employees. The scheme has been closed to new members and existing members ceased to make contributions, with effect from October 2009. Contributions to the scheme are charged to the profit and loss account as incurred. Any pension deficit or surplus held at the balance sheet date has not been recognised in the financial statements.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset over one year.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20242023
Average number of employees during the year2217
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Tangible fixed assets

Vehicles

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 January 2424,00096,40971,206191,615
Additions--1,1191,119
At 31 December 2424,00096,40972,325192,734
Depreciation and impairment
At 01 January 2424,00096,05264,771184,823
Charge for year-3577,0887,445
At 31 December 2424,00096,40971,859192,268
Net book value
At 31 December 24--466466
At 31 December 23-3576,4356,792
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables863,350624,645
Amounts owed by group undertakings806,336401,023
Other debtors424,267407,834
Prepayments and accrued income179,939107,338
Deferred tax asset, debtors9,99413,521
Total2,283,8861,554,361
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables168,667352,909
Taxation and social security220,195138,156
Other creditors1,162,561554,116
Accrued liabilities and deferred income408,210241,958
Total1,959,6331,287,139
7.Pension commitments
The company operates a defined contribution pension scheme for the benefit of its employees. The assets of the scheme are held separately from those of the company in an independently administered fund. At the balance sheet date, unpaid contributions of £41,244 (2023: £16,600) were due to the fund. Unpaid contributions are included in other creditors.
8.Defined benefit obligations
The Collinson Grant Staff Pension Scheme (the Scheme), a defined benefit pension scheme, was closed to new members in October 2009. Existing members' benefits ceased to accrue from that date and they made no further contributions The assets of the Scheme are held separately from those of the company. The company continues to make contributions to the Scheme based on actuarial advice and the recommendations made at each triennial actuarial valuation. Total contributions made in 2024 were £120,000 (2023: £120,000), in addition to administrative costs paid on behalf of the Scheme in 2024 of £31,692 (2023: £21,781). The latest actuarial valuation of the Scheme was carried out on 30th September 2024 by a qualified independent actuary, with a surplus of £671,000 (2021: deficit of £1,197,845).
9.Operating lease commitments
At 31st December 2024, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £32,111 (2023: £16,051)
10.Related party transactions
The company has taken advantage of the exemption available under FRS102 Section 1A Small Entities not to disclose transactions with companies that are under common control.
11.Controlling party
A Collinson is the ultimate controlling party and the sole shareholder of the parent company.
12.Parent-subsidiary relationships
The company's immediate and ultimate parent is Collinson Grant Group Limited, a private company, limited by shares, incorporated in England, registration number 03541703.